1. Personalized medicine in rheumatoid arthritis: how immunogenicity impacts use of TNF inhibitors.;Bodio;Autoimmun Rev,2020
2. Effect of therapeutic drug monitoring vs standard therapy during infliximab induction on disease remission in patients with chronic immune-mediated inflammatory diseases: a randomized clinical trial.;Syversen;JAMA
3. Effect of half-dose vs stable-dose conventional synthetic disease-modifying antirheumatic drugs on disease flares in patients with rheumatoid arthritis in remission: the ARCTIC REWIND randomized trial.;Lillegraven;JAMA
4. Therapeutic drug monitoring of tumor necrosis factor antagonists in Crohn disease: a theoretical construct to apply pharmacokinetics and guidelines to clinical practice.;Vande Casteele;Inflamm Bowel Dis
5. Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation.;Tikhonova;Health Technol Assess,2021